Notice ID: 685b0b99ac2d4abb877e14532bec9841Combined Synopsis/Solicitation
CTL ImmunoSpot S6 Macro M2 Analyzer, Brand Name or Equal, plus two (2) option years of Preventative Maintenance Agreement (PMA)
Archived on June 17, 2022. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 12:00 PM UTC−04:00
- Posted
- May 23, 2022
- Notice type
- Combined Synopsis/Solicitation
- Set-aside
- Total Small Business Set-Aside (FAR 19.5)
- NAICS
- 334516: Analytical Laboratory Instrument Manufacturing
- Agency
- Department of Health and Human ServicesFOOD AND DRUG ADMINISTRATION
Notice details
- Office
- FDA OFFICE OF ACQ GRANT SVCS
- Place of performance
- Silver Spring, MD, 20993
- Last updated
- Dec 4, 2025
Identifiers
- Solicitation number
- FDA-RFQ-CDER-2022-112816
- Notice ID
- 685b0b99ac2d4abb877e14532bec9841
Description
The U. S. Food & Drug Administration, (FDA) Office of Acquisition and Grants Services (OAGS) has a requirement to procure a CTL ImmunoSpot S6 Macro M2 Analyzer, Brand Name or Equal, plus two (2) option years of Preventative Maintenance Agreement (PMA), under solicitation FDA-RFQ-CDER-2022-112816.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
FDA-RFQ-CDER-2022-112816- Combined Synopsis
- Combined SynopsisCurrentMay 23, 2022
CTL ImmunoSpot S6 Macro M2 Analyzer, Brand Name or Equal, plus two (2) option years of Preventative Maintenance Agreement (PMA)
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
(i)This is a combined synopsis/solicitation for commercial items prepared in accordancewith FAR Subpart 12.6, as supplemented with additional information included in thisnotice. This announcement constitutes the only solicitation; proposals are beingrequested, and a separate written solicitation will not be issued. (ii)The solicitation number is 75N98027Q00061. This solicitation is issued as a competitivecombined synopsis/solicitation for commercial products or commercial services (BrandName or Equal in accordance with FAR 52.211-6). The Government intends to award acontract or purchase order resulting from this solicitation using full and open competition.This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitationfor Commercial Products or Commercial Services (and FAR Subpart 13.5, as applicable).The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeksto award a Firm-Fixed-Price (FFP) Purchase Order/Contract in U.S. Dollars (USD) to theresponsible offeror whose proposal represents the best value to the Government. (iii)The solicitation document and incorporated provisions and clauses are those in effectthrough Federal Acquisition Circular 2026-01 and effective date 03/13/2026. (iv)The associated NAICS code is 334516 (Analytical Laboratory InstrumentManufacturing), and the small business size standard is 1,000 employees. ¿This requirement is unrestricted. | 77% | Combined Synopsis | 11/18/2026 |
Brand Name or Equal Teledyne Instruments Liquid Syringe Pump - Model 260x Pump Module (P/N: 681240830) - 2 Qty. per attached specifications along with the following items: 1. Continuous flow dual electric valve package (1/8 inch valves) for Syrixus 1000x, 500x and 260x (P/N: 601267015) - 1 Qty. 2. Electric Valve Controller for SyriXus pumps (P/N: 681240854) - 1 Qty. Amendment 0001: The purpose of this amendment is to provide question and answer as attached as of 11/10/2026. All other terms and conditions remain unchanged. | 74% | Solicitation | 11/20/2026 |
Brand Name or Equal Across International 2R50f Dual-Jacketed Glass Filter Reactor - 110V (2R50f.110) per the attached specifications - 1 Qty. | 74% | Solicitation | 11/25/2026 |
Brand Name or Equal NETZSCH Dilatometer DIL 502 Expedis Supreme with single measuring system (1 Qty.) | 74% | Solicitation | 11/19/2026 |
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98027Q00048/PCA-NIA-12240. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition. This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a firm fixed-price award to the responsible offeror whose proposal represents the best value to the Government. | 73% | Solicitation | 12/14/2026 |
Additional Details
Solicitation Number
FDA-RFQ-CDER-2022-112816
Archive Date
Jun 17, 2022
Office Address
Beltsville, MD, 20705